RxDoctor Payments Data

Michael Bohr, PA

Physician Assistant · Moosic, PANPI 1275082992

Payments from drug & device makers

$9,936in general payments, 2019–2025

Across 657 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • AbbVie$1K
  • Alkermes, Inc.$975
  • Otsuka America Pharmaceutical, Inc.$958
  • Takeda Pharmaceuticals U.S.A., Inc.$799
  • Neurocrine Biosciences, Inc.$622
  • plus $4K from 26 others

What the payments were for

  • Food & beverage$9,87799%
  • Education$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,936 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$12,503
Medicare patients
38
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole17$48,099
Invega SustennaPaliperidone Palmitate21$45,577
VraylarCariprazine Hcl27$36,732
LybalviOlanzapine/Samidorphan Malate12$18,701
TrintellixVortioxetine Hydrobromide26$12,168
Aripiprazole85$8,395
Paliperidone ErPaliperidone34$4,273
Buspirone Hcl126$1,992
Oxcarbazepine38$1,944
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine18$1,853
Carbamazepine ErCarbamazepine12$1,749
Clozapine31$1,655
Trazodone Hcl153$1,378
Divalproex Sodium ErDivalproex Sodium32$1,189
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$958$48,09917 claims
Johnson & JohnsonInvega Sustenna$563$45,57721 claims
AbbVieVraylar$1,042$36,73227 claims
Alkermes, Inc.Lybalvi$975$18,70112 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$799$12,16826 claims
Almatica Pharma LLCSertraline Hcl$49$709103 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Moosic

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →